Although serum CRP has been suggested as a biomarker of infection in acute exacerbations of COPD [33], evidence has shown that antibiotic therapy is guided by procalcitonin levels, a systemic marker of bacterial infection, which safely reduces antibiotic use [34]. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.